Xenetic Biosciences annual revenue
2012
2012
2013
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Xenetic Biosciences Revenue Growth & History (XBIO)
Xenetic Biosciences reported $3.0M in revenue for fiscal 2025, an increase of 19.04% from the previous fiscal year.
View full Xenetic Biosciences company overviewXenetic Biosciences annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $3.0M | $476,127 | +19.04% |
| 2024 | 2024-12-31 | $2.5M | −$39,702 | −1.56% |
| 2023 | 2023-12-31 | $2.5M | $833,061 | +48.80% |
| 2022 | 2022-12-31 | $1.7M | $546,233 | +47.06% |
| 2021 | 2021-12-31 | $1.2M | $723,750 | +165.64% |
| 2020 | 2020-12-31 | $436,942 | $419,876 | +2460.31% |
| 2019 | 2019-12-31 | $17,066 | $17,066 | — |
| 2018 | 2018-12-31 | $0 | −$7.6M | −100.00% |
| 2017 | 2017-12-31 | $7.6M | $4.6M | +152.83% |
| 2016 | 2016-12-31 | $3.0M | $3.0M | — |
| 2015 | 2015-12-31 | $0 | $0 | — |
| 2014 | 2014-12-31 | $0 | −$1.0M | −100.00% |
| 2013 · Dec 31 | 2013-12-31 | $1.0M | $706,397 | +240.60% |
| 2013 · Aug 31 | 2013-08-31 | $96,900 | −$15,886 | −14.09% |
| 2012 · Dec 31 | 2012-12-31 | $293,603 | — | — |
| 2012 · Aug 31 | 2012-08-31 | $112,786 | — | — |
Xenetic Biosciences quarterly revenue
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q1.13
Q2.13
Q2.13
Q3.13
Q1.14
Q1.14
Q1.15
Q3.16
Q3.17
Q3.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $660,601 | $70,704 | +11.99% |
| Q1 2026 | 2026-03-31 | $806,923 | $213,662 | +36.01% |
| Q4 2025 | 2025-12-31 | $766,296 | $117,476 | +18.11% |
| Q3 2025 | 2025-09-30 | $1.0M | $412,714 | +67.19% |
| Q2 2025 | 2025-06-30 | $589,897 | −$136,507 | −18.79% |
| Q1 2025 | 2025-03-31 | $593,261 | $82,444 | +16.14% |
| Q4 2024 | 2024-12-31 | $648,820 | −$23,143 | −3.44% |
| Q3 2024 | 2024-09-30 | $614,243 | $3,069 | +0.50% |
| Q2 2024 | 2024-06-30 | $726,404 | $75,399 | +11.58% |
| Q1 2024 | 2024-03-31 | $510,817 | −$95,027 | −15.69% |
| Q4 2023 | 2023-12-31 | $671,963 | $184,991 | +37.99% |
| Q3 2023 | 2023-09-30 | $611,174 | $196,924 | +47.54% |
| Q2 2023 | 2023-06-30 | $651,005 | $234,295 | +56.22% |
| Q1 2023 | 2023-03-31 | $605,844 | $216,851 | +55.75% |
| Q4 2022 | 2022-12-31 | $486,972 | $154,368 | +46.41% |
| Q3 2022 | 2022-09-30 | $414,250 | $64,981 | +18.60% |
| Q2 2022 | 2022-06-30 | $416,710 | $129,107 | +44.89% |
| Q1 2022 | 2022-03-31 | $388,993 | $197,777 | +103.43% |
| Q4 2021 | 2021-12-31 | $332,604 | $181,272 | +119.78% |
| Q3 2021 | 2021-09-30 | $349,269 | $233,335 | +201.27% |
| Q2 2021 | 2021-06-30 | $287,603 | $174,676 | +154.68% |
| Q1 2021 | 2021-03-31 | $191,216 | $134,467 | +236.95% |
| Q4 2020 | 2020-12-31 | $151,332 | $134,266 | +786.75% |
| Q3 2020 | 2020-09-30 | $115,934 | $115,934 | — |
| Q2 2020 | 2020-06-30 | $112,927 | $112,927 | — |
| Q1 2020 | 2020-03-31 | $56,749 | $56,749 | — |
| Q4 2019 | 2019-12-31 | $17,066 | — | — |
| Q3 2019 | 2019-09-30 | $0 | $0 | — |
| Q2 2019 | 2019-06-30 | $0 | — | — |
| Q1 2019 | 2019-03-31 | $0 | — | — |
| Q3 2018 | 2018-09-30 | $0 | −$85,000 | −100.00% |
| Q3 2017 | 2017-09-30 | $85,000 | $85,000 | — |
| Q3 2016 | 2016-09-30 | $0 | — | — |
| Q1 2015 | 2015-03-31 | $0 | $0 | — |
| Q1 2014 · Mar 31 | 2014-03-31 | $0 | — | — |
| Q1 2014 · Nov 30 | 2013-11-30 | $2,169 | −$30,795 | −93.42% |
| Q3 2013 | 2013-09-30 | $0 | — | — |
| Q2 2013 · Jun 30 | 2013-06-30 | $1.0M | — | — |
| Q2 2013 · May 31 | 2013-05-31 | $39,415 | $2,985 | +8.19% |
| Q1 2013 · Feb 28 | 2013-02-28 | $32,560 | −$3,407 | −9.47% |
| Q1 2013 · Nov 30 | 2012-11-30 | $32,964 | $19,215 | +139.76% |
| Q4 2012 | 2012-08-31 | $26,640 | — | — |
| Q3 2012 | 2012-05-31 | $36,430 | — | — |
| Q2 2012 | 2012-02-29 | $35,967 | — | — |
| Q1 2012 | 2011-11-30 | $13,749 | — | — |
Xenetic Biosciences revenue growth trends
Over the last five reported fiscal years, revenue grew from $436,942 to $3.0M, a compound annual growth rate of 46.78%. Xenetic Biosciences's latest reported quarter, Q2 2026, generated $660,601 in revenue, an increase of 11.99% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Xenetic Biosciences source filings ↗